This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43422526
rdf:type
wikibase:Item
schema:description
2012年学术文章 scientific article published on 14 April 2012 bilimsel makale artikulong pang-agham επιστημονικό άρθρο scienca artikolo vitskapeleg artikkel article científic scientific article published on 14 April 2012 2012年学术文章 مقالة علمية نشرت في 14 أبريل 2012 სამეცნიერო სტატია บทความทางวิทยาศาสตร์ 2012年學術文章 videnskabelig artikel artigo científico 2012年の論文 научна статия vitenskapelig artikkel наукова стаття, опублікована у квітні 2012 2012年學術文章 artículu científicu espublizáu en 2012 tieteellinen artikkeli article scientific 2012年学术文章 vedecký článok tudományos cikk vetenskaplig artikel научни чланак ১৪ এপ্রিল ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ artikel ilmiah 2012年学术文章 wissenschaftlicher Artikel 2012年學術文章 bài báo khoa học artigo científico articolo scientifico 2012년 논문 artículo científico publicado en 2012 scientific article published on 14 April 2012 artikull shkencor wetenschappelijk artikel artykuł naukowy 2012年学术文章 научная статья 2012年學術文章 2012年学术文章 научни чланак מאמר מדעי teaduslik artikkel 2012年學術文章 artigo científico article scientifique vědecký článek articol științific 2012 nî lūn-bûn naučni članak
p:P577
wds:Q43422526-5B37E6AA-36CD-4A60-8574-2CA3FB1A1673
wdt:P577
2012-04-14T00:00:00Z
p:P2093
wds:Q43422526-12C538AA-1C9F-4E96-BF39-6165958ED1D5 wds:Q43422526-20A898EA-FFCB-4CDD-8FBB-D1A3991285C4 wds:Q43422526-052C2C2C-C2F5-4C5E-8037-6AB1DF3EAE2E wds:Q43422526-3B4218CD-E7C1-4A8E-822C-23F35FBDFF62 wds:Q43422526-26FCE8F0-F459-44D5-A760-389B3E43E562 wds:Q43422526-3B1F03F2-6C56-4E7C-8DF0-3CF5C4B02171 wds:Q43422526-66AC80CF-D344-4446-BE5A-77FE5D7B8855 wds:Q43422526-78739161-82D9-4349-91A9-A6317D2B3086 wds:Q43422526-C3E85698-ADC5-450E-9864-CEEF2237B7B8 wds:Q43422526-8A02B759-1C3C-414B-A19F-C7A9404B7D4F wds:Q43422526-9E37BDB9-8A27-48EF-9B92-D8537DE9D1E2 wds:Q43422526-ED3405A8-3B40-4228-A8EB-804EE501C2EF
wdt:P2093
O Chapet T Conroy J P Gerard L Mineur G Calais N Methy L Radosevic-Jelic O Bouché P Maingon J F Bosset L Collette F Bonnetain
rdfs:label
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
skos:prefLabel
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
schema:name
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
p:P1476
wds:Q43422526-E24C5559-96D3-4D7E-B951-57B45F09D816
wdt:P1476
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
p:P304
wds:Q43422526-0D9A5288-EDE4-4BDB-B824-8887693A4731
wdt:P304
1781-1790
p:P31
wds:Q43422526-417236A0-BA4E-4EB2-8028-D3082793A179 wds:Q43422526-b2a50f26-3fd7-46cf-8c76-1d820d4d0116
wdt:P31
wd:Q815382 wd:Q13442814
p:P921
wds:Q43422526-3B68DC6B-7A8D-4034-ACD5-A4F9C2F034E5
wdt:P921
wd:Q5090613
p:P698
wds:Q43422526-77C131EF-1503-4D9A-BF3A-E11AA5C1CBEB
wdtn:P698
n12:22507892
wdt:P698
22507892
p:P1433
wds:Q43422526-7271F2F0-50A0-4DE1-A8A1-0330D8E6A241
wdt:P1433
wd:Q332260
p:P433
wds:Q43422526-D39974B3-9275-4DE0-A156-4B9DCADD8AE5
p:P478
wds:Q43422526-AE6349E2-7B73-4F06-BF75-E61212FDDDD6
wdt:P433
12
wdt:P478
48
p:P356
wds:Q43422526-66765D13-E0BB-41DC-9E2B-313A70AFA320
wdtn:P356
n11:J.EJCA.2012.03.016
wdt:P356
10.1016/J.EJCA.2012.03.016
p:P5875
wds:Q43422526-6A266D40-546D-4781-84A4-B112EA63339A
wdt:P5875
224051875